(146) Low-Dose Naltrexone in the Treatment of Fibromyalgia: A Retrospective Analysis

The first scientific reference of fibromyalgia as a medical disorder occurred in 1981. Since then, pain management experts have continuously debated diagnosis criteria, potential pathologies, and viable treatment options due to the complex nature of the disease. For both patient and clinician, the efficacy of current pharmacologic treatments can be frustrating. The clinical benefit of medications is often modest at best. In fact, the 2016 European League Against Rheumatism (EULAR) guideline for managing fibromyalgia could only endorse a 'weak for' recommendation for medication management based on currently available evidence.
Source: The Journal of Pain - Category: Materials Science Authors: Source Type: research